Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides.

Identifieur interne : 004869 ( Main/Exploration ); précédent : 004868; suivant : 004870

Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides.

Auteurs : P T Ho [États-Unis] ; K. Ishiguro ; E. Wickstrom ; A C Sartorelli

Source :

RBID : pubmed:1821654

Descripteurs français

English descriptors

Abstract

A series of phosphodiester and phosphorothioate antisense oligodeoxynucleotides were synthesized against the human transferrin receptor (TfR). The phosphorothioate analogs exhibited marked biologic efficacy in culture, as assessed by inhibition of surface TfR content and HL-60 cell growth, whereas their unmodified phosphodiester counterparts were ineffective. Phosphorothioate oligodeoxynucleotides were more resistant to hydrolysis by serum and cellular nucleases and were more readily taken up by cells than phosphodiesters, thus providing a partial explanation for the differences in biologic activity. A length effect was observed, with antisense 30-mers exhibiting greater TfR inhibitory activity than 17-mers. The degree of receptor inhibition observed, however, was not sequence dependent, suggesting that the phosphorothioate oligodeoxynucleotides may have pleiotropic activities in eukaryotic cells in addition to inhibiting gene expression by classic antisense complementary binding to mRNA.

DOI: 10.1089/ard.1991.1.329
PubMed: 1821654


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides.</title>
<author>
<name sortKey="Ho, P T" sort="Ho, P T" uniqKey="Ho P" first="P T" last="Ho">P T Ho</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Department of Pharmacology, Yale University School of Medicine, New Haven</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ishiguro, K" sort="Ishiguro, K" uniqKey="Ishiguro K" first="K" last="Ishiguro">K. Ishiguro</name>
</author>
<author>
<name sortKey="Wickstrom, E" sort="Wickstrom, E" uniqKey="Wickstrom E" first="E" last="Wickstrom">E. Wickstrom</name>
</author>
<author>
<name sortKey="Sartorelli, A C" sort="Sartorelli, A C" uniqKey="Sartorelli A" first="A C" last="Sartorelli">A C Sartorelli</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1821654</idno>
<idno type="pmid">1821654</idno>
<idno type="doi">10.1089/ard.1991.1.329</idno>
<idno type="wicri:Area/PubMed/Corpus">002A08</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A08</idno>
<idno type="wicri:Area/PubMed/Curation">002A08</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A08</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002830</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002830</idno>
<idno type="wicri:Area/Ncbi/Merge">000578</idno>
<idno type="wicri:Area/Ncbi/Curation">000578</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000578</idno>
<idno type="wicri:doubleKey">1050-5261:1991:Ho P:non:sequence:specific</idno>
<idno type="wicri:Area/Main/Merge">004944</idno>
<idno type="wicri:Area/Main/Curation">004869</idno>
<idno type="wicri:Area/Main/Exploration">004869</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides.</title>
<author>
<name sortKey="Ho, P T" sort="Ho, P T" uniqKey="Ho P" first="P T" last="Ho">P T Ho</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Department of Pharmacology, Yale University School of Medicine, New Haven</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ishiguro, K" sort="Ishiguro, K" uniqKey="Ishiguro K" first="K" last="Ishiguro">K. Ishiguro</name>
</author>
<author>
<name sortKey="Wickstrom, E" sort="Wickstrom, E" uniqKey="Wickstrom E" first="E" last="Wickstrom">E. Wickstrom</name>
</author>
<author>
<name sortKey="Sartorelli, A C" sort="Sartorelli, A C" uniqKey="Sartorelli A" first="A C" last="Sartorelli">A C Sartorelli</name>
</author>
</analytic>
<series>
<title level="j">Antisense research and development</title>
<idno type="ISSN">1050-5261</idno>
<imprint>
<date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Base Sequence</term>
<term>Biological Transport</term>
<term>Cell Division (drug effects)</term>
<term>Cell Line</term>
<term>Drug Stability</term>
<term>Gene Expression Regulation, Neoplastic (drug effects)</term>
<term>Humans</term>
<term>Kinetics</term>
<term>Leukemia, Promyelocytic, Acute</term>
<term>Molecular Sequence Data</term>
<term>Oligonucleotides, Antisense (chemical synthesis)</term>
<term>Oligonucleotides, Antisense (metabolism)</term>
<term>Oligonucleotides, Antisense (pharmacology)</term>
<term>Organothiophosphates (pharmacology)</term>
<term>Receptors, Transferrin (drug effects)</term>
<term>Receptors, Transferrin (genetics)</term>
<term>Receptors, Transferrin (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cinétique</term>
<term>Division cellulaire ()</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Leucémie aiguë promyélocytaire</term>
<term>Lignée cellulaire</term>
<term>Oligonucléotides antisens (métabolisme)</term>
<term>Oligonucléotides antisens (pharmacologie)</term>
<term>Oligonucléotides antisens (synthèse chimique)</term>
<term>Organothiophosphates (pharmacologie)</term>
<term>Récepteurs à la transferrine ()</term>
<term>Récepteurs à la transferrine (génétique)</term>
<term>Récepteurs à la transferrine (métabolisme)</term>
<term>Régulation de l'expression des gènes tumoraux ()</term>
<term>Stabilité de médicament</term>
<term>Séquence nucléotidique</term>
<term>Transport biologique</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en">
<term>Oligonucleotides, Antisense</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Cell Division</term>
<term>Gene Expression Regulation, Neoplastic</term>
<term>Receptors, Transferrin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Receptors, Transferrin</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Récepteurs à la transferrine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Oligonucleotides, Antisense</term>
<term>Receptors, Transferrin</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Oligonucléotides antisens</term>
<term>Récepteurs à la transferrine</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Oligonucléotides antisens</term>
<term>Organothiophosphates</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Oligonucleotides, Antisense</term>
<term>Organothiophosphates</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr">
<term>Oligonucléotides antisens</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Base Sequence</term>
<term>Biological Transport</term>
<term>Cell Line</term>
<term>Drug Stability</term>
<term>Humans</term>
<term>Kinetics</term>
<term>Leukemia, Promyelocytic, Acute</term>
<term>Molecular Sequence Data</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cinétique</term>
<term>Division cellulaire</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Leucémie aiguë promyélocytaire</term>
<term>Lignée cellulaire</term>
<term>Récepteurs à la transferrine</term>
<term>Régulation de l'expression des gènes tumoraux</term>
<term>Stabilité de médicament</term>
<term>Séquence nucléotidique</term>
<term>Transport biologique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A series of phosphodiester and phosphorothioate antisense oligodeoxynucleotides were synthesized against the human transferrin receptor (TfR). The phosphorothioate analogs exhibited marked biologic efficacy in culture, as assessed by inhibition of surface TfR content and HL-60 cell growth, whereas their unmodified phosphodiester counterparts were ineffective. Phosphorothioate oligodeoxynucleotides were more resistant to hydrolysis by serum and cellular nucleases and were more readily taken up by cells than phosphodiesters, thus providing a partial explanation for the differences in biologic activity. A length effect was observed, with antisense 30-mers exhibiting greater TfR inhibitory activity than 17-mers. The degree of receptor inhibition observed, however, was not sequence dependent, suggesting that the phosphorothioate oligodeoxynucleotides may have pleiotropic activities in eukaryotic cells in addition to inhibiting gene expression by classic antisense complementary binding to mRNA.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Connecticut</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Ishiguro, K" sort="Ishiguro, K" uniqKey="Ishiguro K" first="K" last="Ishiguro">K. Ishiguro</name>
<name sortKey="Sartorelli, A C" sort="Sartorelli, A C" uniqKey="Sartorelli A" first="A C" last="Sartorelli">A C Sartorelli</name>
<name sortKey="Wickstrom, E" sort="Wickstrom, E" uniqKey="Wickstrom E" first="E" last="Wickstrom">E. Wickstrom</name>
</noCountry>
<country name="États-Unis">
<region name="Connecticut">
<name sortKey="Ho, P T" sort="Ho, P T" uniqKey="Ho P" first="P T" last="Ho">P T Ho</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004869 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004869 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:1821654
   |texte=   Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:1821654" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021